Table 4.
Confidence-boosting beliefs (PPG%) | Hesitancy-fanning beliefs (PPG%) | |
---|---|---|
Overall | Safety (19.04%) Effectiveness (17.87%) Important others think I should get (17.62%) Help reach herd immunity (16.27%) Help go back to normal life (15.21%) Help protect vulnerable population (14.40%) Confidence in explaining pro and con (13.43%) Confidence in explaining science (12.96%) Confidence in explaining FDA process (11.82%) |
The vaccine was developed faster due to political pressure (12.33%) Don’t know about mRNA safety yet (12.56%) Approval process was too hasty (11.62%) |
Rural | Safety (22.48%) Important others think I should get (20.94%) Effectiveness (20.45%) Help reach herd immunity (20.18%) Help go back to normal life (18.48%) Help protect vulnerable population (17.34%) Confidence in explaining pro and con (13.94%) Confidence in explaining science (12.41%) |
The vaccine was developed faster due to political pressure (12.70%) Don’t know about mRNA safety yet (11.85%) |
Urban | Safety (15.65%) Effectiveness (15.56%) Confidence in explaining science (13.52%) Confidence in explaining pro and con (12.99%) Confidence in explaining FDA process (12.86%) Important others think I should get (12.69%) |
The vaccine was developed faster due to political pressure (14.18%) Don’t know about mRNA safety yet (11.85%) Conflict/contradictory information (13.01%) Negative information withheld (11.68%) |
Clinical | Safety (17.44%) Effectiveness (15.90%) Important others think I should get (14.80%) Help reach herd immunity (14.59%) Help go back to normal life (13.45%) Help protect vulnerable population (12.63%) |
The vaccine was developed faster due to political pressure (13.00%) |
Non-clinical | Safety (20.08%) Effectiveness (19.25%) Important others think I should get (18.66%) Help reach herd immunity (16.68%) Help go back to normal life (15.37%) Confidence in explaining pro and con (14.91%) Help protect vulnerable population (14.57%) Confidence in explaining science (14.56%) Confidence in explaining FDA process (12.75%) |
Don’t know about mRNA safety yet (13.62%) Approval process was too hasty (12.36%) The vaccine was developed faster due to political pressure (11.85%) Limited reliable information (11.83%) |
Notes: top-ranked beliefs identified using a global cut-off point (PPG = 11.62%) corresponding to the 75th percentile in the distribution of PPG scores across all the beliefs in the overall sample. Outcome is vaccine acceptance.